Heart Test Laboratories, Inc. (HSCS)
NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 5.77M |
| Enterprise value | -247.52k |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 100.88 |
| Price/book (mrq) | 0.67 |
| Enterprise value/revenue | 1.12k |
| Enterprise value/EBITDA | -1.81 |
Trading information
Stock price history
| Beta (5Y monthly) | N/A |
| 52-week change 3 | -90.74% |
| S&P500 52-week change 3 | 26.27% |
| 52-week high 3 | 1.2800 |
| 52-week low 3 | 0.0850 |
| 50-day moving average 3 | 0.1104 |
| 200-day moving average 3 | 0.2987 |
Share statistics
| Avg vol (3-month) 3 | 1.86M |
| Avg vol (10-day) 3 | 1.21M |
| Shares outstanding 5 | 65.56M |
| Implied shares outstanding 6 | 66.9M |
| Float 8 | 56.25M |
| % held by insiders 1 | 16.01% |
| % held by institutions 1 | 2.09% |
| Shares short (30 Apr 2024) 4 | 617.59k |
| Short ratio (30 Apr 2024) 4 | 0.26 |
| Short % of float (30 Apr 2024) 4 | 0.96% |
| Short % of shares outstanding (30 Apr 2024) 4 | 0.94% |
| Shares short (prior month 28 Mar 2024) 4 | 135.26k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Apr 2023 |
| Most-recent quarter (mrq) | 31 Jan 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -10,376.75% |
Management effectiveness
| Return on assets (ttm) | -52.73% |
| Return on equity (ttm) | -152.61% |
Income statement
| Revenue (ttm) | 18.6k |
| Revenue per share (ttm) | 0.00 |
| Quarterly revenue growth (yoy) | 653.80% |
| Gross profit (ttm) | N/A |
| EBITDA | -6M |
| Net income avi to common (ttm) | -6.39M |
| Diluted EPS (ttm) | -0.3500 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 7.08M |
| Total cash per share (mrq) | 0.11 |
| Total debt (mrq) | 1.06M |
| Total debt/equity (mrq) | 12.27% |
| Current ratio (mrq) | 5.09 |
| Book value per share (mrq) | 0.14 |
Cash flow statement
| Operating cash flow (ttm) | -6.4M |
| Levered free cash flow (ttm) | -4.89M |
© 2024 Yahoo. All rights reserved.